Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feld

Showing results (221-230 of 451) with videos related to

Pageof 46
Sort By:
Gut|August 30, 2019
Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study)Kin Seng Liem, Scott Fung, David K Wong, et al.
ACS Nano|May 10, 2021
Diagnosing Antibiotic Resistance Using Nucleic Acid Enzymes and Gold NanoparticlesMohamed A Abdou Mohamed, Hannah N Kozlowski, Jisung Kim, et al.
Scientific Reports|October 21, 2016
Hepatitis C RNA assay differences in results: Potential implications for shortened therapy and determination of Sustained Virologic ResponseGavin Cloherty, Stephane Chevaliez, Christoph Sarrazin, et al.
Hepatology (Baltimore, Md.)|April 5, 2014
Ribavirin improves the IFN-γ response of natural killer cells to IFN-based therapy of hepatitis C virus infectionJens M Werner, Elisavet Serti, Xenia Chepa-Lotrea, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 11, 2023
Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort studyAndrew B Mendlowitz, Karen E Bremner, Murray Krahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseasesAndrew S Artz, Mark R Somerfield, Jordan J Feld, et al.
Gastroenterology|January 30, 2007
Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis CYing Huang, Jordan J Feld, Ronda K Sapp, et al.
ACS Nano|February 10, 2015
Integrated quantum dot barcode smartphone optical device for wireless multiplexed diagnosis of infected patientsKevin Ming, Jisung Kim, Mia J Biondi, et al.
Current Oncology (Toronto, Ont.)|June 4, 2020
Nonsurgical management of advanced hepatocellular carcinoma: a clinical practice guidelineB M Meyers, J Knox, R Cosby, et al.
Gastroenterology|January 31, 2012
Hepatic cell-type specific gene expression better predicts HCV treatment outcome than IL28B genotypeIan McGilvray, Jordan J Feld, Limin Chen, et al.
Pageof 46

Showing results (221-230 of 451) with videos related to

Sort By:
Pageof 46
Gut|August 30, 2019
Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study)Kin Seng Liem, Scott Fung, David K Wong, et al.
ACS Nano|May 10, 2021
Diagnosing Antibiotic Resistance Using Nucleic Acid Enzymes and Gold NanoparticlesMohamed A Abdou Mohamed, Hannah N Kozlowski, Jisung Kim, et al.
Scientific Reports|October 21, 2016
Hepatitis C RNA assay differences in results: Potential implications for shortened therapy and determination of Sustained Virologic ResponseGavin Cloherty, Stephane Chevaliez, Christoph Sarrazin, et al.
Hepatology (Baltimore, Md.)|April 5, 2014
Ribavirin improves the IFN-γ response of natural killer cells to IFN-based therapy of hepatitis C virus infectionJens M Werner, Elisavet Serti, Xenia Chepa-Lotrea, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 11, 2023
Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort studyAndrew B Mendlowitz, Karen E Bremner, Murray Krahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseasesAndrew S Artz, Mark R Somerfield, Jordan J Feld, et al.
Gastroenterology|January 30, 2007
Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis CYing Huang, Jordan J Feld, Ronda K Sapp, et al.
ACS Nano|February 10, 2015
Integrated quantum dot barcode smartphone optical device for wireless multiplexed diagnosis of infected patientsKevin Ming, Jisung Kim, Mia J Biondi, et al.
Current Oncology (Toronto, Ont.)|June 4, 2020
Nonsurgical management of advanced hepatocellular carcinoma: a clinical practice guidelineB M Meyers, J Knox, R Cosby, et al.
Gastroenterology|January 31, 2012
Hepatic cell-type specific gene expression better predicts HCV treatment outcome than IL28B genotypeIan McGilvray, Jordan J Feld, Limin Chen, et al.
Pageof 46